Lead Product(s): Propofol
Therapeutic Area: Neurology Product Name: Diprivan
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Premier Intermediates Pvt.Ltd.
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership July 13, 2020
Premier through its ProvideGx™ program, has partnered with Fresenius Kabi to supply Diprivan® (propofol) injectable emulsion, USP to healthcare providers, helping to stabilize the long-term supply of a medication vital for COVID-19 patient care.